...
首页> 外文期刊>Biomacromolecules >Insights into siRNA Transfection in Suspension: Efficient Gene Silencing in Human Mesenchymal Stem Cells Encapsulated in Hyaluronic Acid Hydrogel
【24h】

Insights into siRNA Transfection in Suspension: Efficient Gene Silencing in Human Mesenchymal Stem Cells Encapsulated in Hyaluronic Acid Hydrogel

机译:悬浮液中SiRNA转染的见解:在透明质酸水凝胶中包封的人间充质干细胞中有效基因沉默

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Small interfering RNAs (siRNAs) are powerful tools for post-transcriptional gene silencing, which offers enormous opportunities for tissue engineering applications. However, poor serum stability, inefficient intracellular delivery, and inevitable toxicity of transfection reagents are the key barriers for their clinical translation. Thus, innovative strategies that allow safe and efficient intracellular delivery of the nucleic acid drugs at the desired site is urgently needed for a smooth clinical translation of therapeutically appealing siRNA-based technology. In this regard, we have developed an innovative siRNA transfection protocol that employs a short incubation time of just 5 min. This allows easy transfection in suspension followed by transplantation of the cells in a hyaluronic acid (HA) hydrogel system. We also report here the unique ability of siRNA to bind HA that was quantified by siRNA release and rheological characterization of the HA-hydrogel. Such interactions also showed promising results to deliver functional siRNA in suspension transfection conditions within 30 min using native HA, although removal of excess HA by centrifugation seem to be essential. In the 2D experiments, suspension transfection of hMSCs with RNAiMAX resulted in approximate to 90% gene silencing (with or without removal of the excess reagent by centrifugation), while HA demonstrated a modest approximate to 40% gene silencing after removal of excess reagent after 30 min. Transplantation of such transfected cells in the HA-hydrogel system demonstrated an improved knockdown (approximate to 90% and approximate to 60% with RNAiMAX and HA respectively after 48 h), with lower cytotoxicity (up to 5-days) as determined by PrestoBlue assay. The gene silencing efficiency in the 2D and 3D conditions were also confirmed at the protein levels by Western blot analysis. We postulate this novel transfection method could be applied for in vivo applications as it allows minimal manipulation of cells that are to be transplanted and reduce toxicity.
机译:小干扰RNA(siRNA)是转录后基因沉默的强大工具,为组织工程应用提供了巨大的机会。然而,血清稳定性差,效率低下的细胞内递送以及转染试剂的必然毒性是其临床翻译的关键障碍。因此,允许在所需部位处允许安全和高效的细胞内递送核酸药物的创新策略,以进行平稳的临床翻译治疗吸引力的基于siRNA的技术。在这方面,我们开发了一种创新的siRNA转染方案,即在短短5分钟的时间内使用短暂的孵化时间。这允许在悬浮液中易于转染,然后在透明质酸(HA)水凝胶系统中移植细胞。我们还报告了SiRNA与HA与Ha-Hydrogel的流变表征量化的siRNA结合HA的独特能力。这种相互作用还表明有前途的结果在使用天然HA内在30分钟内在30分钟内递送悬浮转染条件的功能siRNA,但通过离心除去过量的HA似乎是必不可少的。在2D实验中,用RNaimax悬浮转染HMSCs导致90%基因沉默(有或不通过离心除去过量的试剂),而HA证明了在30后除去过量试剂后的40%基因沉默的温度近似闵。在Ha-hydrogel系统中的这种转染的细胞移植在48小时后分别证明了改进的敲低(近似为90%,并分别在48小时后与Rnaimax和HA近似为60%),具有较低的细胞毒性(最多5天),如prestoblue测定法测定。通过Western印迹分析,还在蛋白质水平确认了2D和3D条件中的基因沉默效率。我们假设该新型转染方法可以在体内应用中应用,因为它允许待移植和减少毒性的细胞最小化。

著录项

  • 来源
    《Biomacromolecules》 |2019年第3期|共8页
  • 作者单位

    Uppsala Univ Div Polymer Chem Dept Chem Translat Chem Biol Lab Angstrom Lab S-75121 Uppsala Sweden;

    Uppsala Univ Div Polymer Chem Dept Chem Translat Chem Biol Lab Angstrom Lab S-75121 Uppsala Sweden;

    Uppsala Univ Div Polymer Chem Dept Chem Translat Chem Biol Lab Angstrom Lab S-75121 Uppsala Sweden;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号